智通财经APP获悉，剂泰科技-P(07666)早盘涨超7%，截至发稿，涨7.58%，报14.25港元，成交额178.06万港元。
消息面上，近日，剂泰科技宣布与全球顶级健康投资与创新平台Deerfield达成战略联盟。Deerfield将就剂泰科技自研AI纳米递送平台NanoForge及其驱动解决方案和核心管线项目在全球临床开发和商务拓展举措方面开展深度合作。NanoForge已实现覆盖AI蛋白生成、体内递送技术及下一代免疫疗法开发的完整链条。其中，AiProtein平台可用于新型治疗性蛋白的快速发现与优化，包括T细胞衔接器（TCE）、体内蛋白疗法以及其他先进免疫调节治疗模式。
据悉，双方的战略联盟旨在深度整合剂泰科技在AI驱动蛋白工程、体内免疫治疗及可编程生物药领域的专有差异化技术和Deerfield在转化医学、临床开发、医疗健康创新及全球合作等方面深厚的产业经验和专业能力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.